
Alex Pieper
@PiepsTweeets
Followers
70
Following
60
Media
2
Statuses
13
PGY2 @PennRadiology. Alumni of @UWMSTP interested in using imaging/image guided procedures to study cancer immunology and immunotherapy
Philadelphia, PA
Joined March 2021
RT @PennRadRes: Dr. Alex Pieper of @PennRadiology presenting his latest work on #Histoplasty modulation of tumor #microenvironment @SIRspec….
0
4
0
Check out our @UWCarbone group’s latest publication on #Cancer #Immunotherapy with @SpringerNature in Cancer Immunology Immunotherapy. We examine how preclinical models and conditions change responses to an in-situ cancer vaccine
link.springer.com
Cancer Immunology, Immunotherapy - The in-situ vaccine using CpG oligodeoxynucleotide combined with OX40 agonist antibody (CpG + OX40) has been shown to be an effective therapy...
0
3
12
RT @eberger_do: Co-res & future radiologist @PiepsTweeets with the lecture of the year so far on histotripsy #medtwitter #irad
https://t.co….
0
3
0
RT @PeterCarlsonMD: Excited to share my work with @ZachMorrisMDPhD and @RPatelMDPHD showing that we can use low-dose systemic molecular tar….
0
2
0
Before and after 8 years, 2 degrees, and 37 iterations of the iPhone. Thankful to my family, friends, and mentors for all they’ve given me & excited about my next stop in MKE for my TY at St. Luke’s before starting @PennRadiology in June 2023.
0
2
29
RT @UWMSTP: Yang Hu - Pathology, @StanfordPath .@PiepsTweeets - Diagnostic Radiology (research), @PennRadiology .@RigbyMJ - Neurology, @May….
0
2
0
Another wonderful demonstration of the collaborative research atmosphere here at @UWCarbone with this recent publication in @FrontImmunol. Our team was able to show the importance of radiation therapy for an effective anti-tumor response to an in situ cancer vaccine.
New Research: Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models: Introduction Combining CpG oligodeoxynucleotides with anti-OX40 agonist… #immunology.
0
2
7
#SITC21 swing by poster #598 today to check out some exciting work on radioimmunotherapy by @UWCarbone’s Dan Spiegelman!! Keep your 👀 on @FrontImmunol in the coming days for more details on this project
0
0
4
Really proud of the work our team put into this manuscript recently published by @jitcancer! Thanks to the strong collaboration between @UWCarbone and @NektarNews, a clinical trial investigating this combination in patients w/ HNSCC is now open at UW.
New #JITC article: Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice @PiepsTweeets
0
2
9
RT @UWMSTP: #PubAlert! New publication co-authored by M4 @PeterCarlsonMD and G4 @PiepsTweeets in Frontiers in Oncology! . Combination of Be….
pubmed.ncbi.nlm.nih.gov
Surgical resection or hypo-fractionated radiation therapy (RT) in early-stage non-small cell lung cancer (NSCLC) achieves local tumor control, but metastatic relapse remains a challenge. We hypothe...
0
1
0